Loki Home

Research Interests

Funding Opportunities


UI Login Guest Login

Browse by Investigator Last Name

Browse Research

Photo of Lyse Norian, PhD

Lyse Norian, PhD

This person no longer has an active appointment with the University of Iowa.


Research Interests

MeSH Terms from Publications

Research Summary

Recent Publications

Show publications
  1. Diet-induced obesity alters dendritic cell function in the presence and absence of tumor growth. J Immunol 189(3):1311-21, 2012. [PubMed]
  2. Eradication of metastatic renal cell carcinoma after adenovirus-encoded TNF-related apoptosis-inducing ligand (TRAIL)/CpG immunotherapy. PLoS One 7(2):e31085, 2012. [PubMed]
  3. Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism. Cancer Res 69(7):3086-94, 2009. [PubMed]
  4. TRAIL gene therapy: from preclinical development to clinical application. Curr Gene Ther 9(1):9-19, 2009. [PubMed]
  5. An antibiotic-responsive mouse model of fulminant ulcerative colitis. PLoS Med 5(3):e41, 2008. [PubMed]
  6. Rapid maturation of effector T cells in tumors, but not lymphoid organs, during tumor regression. PLoS One 2(9):e821, 2007. [PubMed]
  7. T cell-mediated delay of spontaneous mammary tumor onset: increased efficacy with in vivo versus in vitro activation. J Immunol 174(8):4662-9, 2005. [PubMed]
  8. No intrinsic deficiencies in CD8+ T cell-mediated antitumor immunity with aging. J Immunol 173(2):835-44, 2004. [PubMed]
  9. CD4-directed peptide vaccination augments an antitumor response, but efficacy is limited by the number of CD8+ T cell precursors. J Immunol 172(7):4215-24, 2004. [PubMed]
  10. The regulation of CD95 (Fas) ligand expression in primary T cells: induction of promoter activation in CD95LP-Luc transgenic mice. J Immunol 164(9):4471-80, 2000. [PubMed]